
BLAC
Bellevue Life Sciences Acquisition Corp
- Overview
- Forecast
- Valuation
- Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
43.48M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
4.04M
EV
8.75M
EV/OCF(TTM)
--
P/S(TTM)
--
Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.
Show More
0 Analyst Rating

Wall Street analysts forecast BLAC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLAC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell

Current: 0

Low
Averages
High

Current: 0

Low
Averages
High
The End
See All Ratings

No Data
Valuation Metrics
The current forward P/E ratio for Bellevue Life Sciences Acquisition Corp (BLAC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Bellevue Life Sciences Acquisition Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2024Q3
YoY :
+10.65%
-454.13K
Operating Profit
FY2024Q3
YoY :
-395.41%
-230.96K
Net Income after Tax
FY2024Q3
YoY :
-700.00%
-0.06
EPS - Diluted
FY2024Q3
YoY :
+58.41%
-226.88K
Free Cash Flow
FY2024Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
BLAC News & Events
News
2.0
02-14Business InsiderBellevue Life Sciences Acquisition Corp trading resumes
2.0
02-14Business InsiderBellevue Life Sciences Acquisition Corp trading halted, volatility trading pause
4.5
02-14BenzingaUS Stocks Edge Higher; Deere Posts Upbeat Earnings
Sign Up For More News
People Also Watch

ASRV
Ameriserv Financial Inc
3.070
USD
-1.60%

KZR
Kezar Life Sciences Inc
4.450
USD
+3.49%

BODI
Beachbody Company Inc
4.220
USD
+5.76%

MOBX
MOBIX LABS, INC.
1.150
USD
-2.54%

ABLV
Able View Global Inc
1.119
USD
+7.60%

KELYB
Kelly Services Inc
12.320
USD
+0.41%

FORL
Four Leaf Acquisition Corp
11.350
USD
-1.82%

CCLD
CareCloud Inc
2.410
USD
+2.12%

MNY
MoneyHero Ltd
1.720
USD
-4.97%

TACT
TransAct Technologies Inc
3.770
USD
-0.79%
FAQ

What is Bellevue Life Sciences Acquisition Corp (BLAC) stock price today?
The current price of BLAC is 0 USD — it has decreased -134.22 % in the last trading day.

What is Bellevue Life Sciences Acquisition Corp (BLAC)'s business?

What is the price predicton of BLAC Stock?

What is Bellevue Life Sciences Acquisition Corp (BLAC)'s revenue for the last quarter?

What is Bellevue Life Sciences Acquisition Corp (BLAC)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Bellevue Life Sciences Acquisition Corp (BLAC)'s fundamentals?

How many employees does Bellevue Life Sciences Acquisition Corp (BLAC). have?
